Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

May 01, 2004; Volume 32,Issue 5
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Ang, Catharina Y. W.

    1. You have access
      INDUCTION AND INHIBITION OF CYTOCHROMES P450 BY THE ST. JOHN'S WORT CONSTITUENT HYPERFORIN IN HUMAN HEPATOCYTE CULTURES
      Bernard J. Komoroski, Shimin Zhang, Hongbo Cai, J. Matthew Hutzler, Reginald Frye, Timothy S. Tracy, Stephen C. Strom, Thomas Lehmann, Catharina Y. W. Ang, Yan Yan Cui and Raman Venkataramanan
      Drug Metabolism and Disposition May 2004, 32 (5) 512-518; DOI: https://doi.org/10.1124/dmd.32.5.512

B

  1. Bombail, Vincent

    1. You have access
      ROLE OF Sp1, C/EBPα, HNF3, AND PXR IN THE BASAL- AND XENOBIOTIC-MEDIATED REGULATION OF THE CYP3A4 GENE
      Vincent Bombail, Kevin Taylor, G. Gordon Gibson and Nick Plant
      Drug Metabolism and Disposition May 2004, 32 (5) 525-535; DOI: https://doi.org/10.1124/dmd.32.5.525
  2. Bonner, Johanne

    1. You have access
      PHARMACOKINETICS AND METABOLISM OF LUMIRACOXIB IN HEALTHY MALE SUBJECTS
      James B. Mangold, Helen Gu, Lolita C. Rodriguez, Johanne Bonner, Janet Dickson and Christiane Rordorf
      Drug Metabolism and Disposition May 2004, 32 (5) 566-571; DOI: https://doi.org/10.1124/dmd.32.5.566
  3. Bosron, William F.

    1. You have access
      HYDROLYSIS OF IRINOTECAN AND ITS OXIDATIVE METABOLITES, 7-ETHYL-10-[4-N-(5-AMINOPENTANOIC ACID)-1-PIPERIDINO] CARBONYLOXYCAMPTOTHECIN AND 7-ETHYL-10-[4-(1-PIPERIDINO)-1-AMINO]-CARBONYLOXYCAMPTOTHECIN, BY HUMAN CARBOXYLESTERASES CES1A1, CES2, AND A NEWLY EXPRESSED CARBOXYLESTERASE ISOENZYME, CES3
      Sonal P. Sanghani, Sara K. Quinney, Tyler B. Fredenburg, Wilhelmina I. Davis, Daryl J. Murry and William F. Bosron
      Drug Metabolism and Disposition May 2004, 32 (5) 505-511; DOI: https://doi.org/10.1124/dmd.32.5.505

C

  1. Cai, Hongbo

    1. You have access
      INDUCTION AND INHIBITION OF CYTOCHROMES P450 BY THE ST. JOHN'S WORT CONSTITUENT HYPERFORIN IN HUMAN HEPATOCYTE CULTURES
      Bernard J. Komoroski, Shimin Zhang, Hongbo Cai, J. Matthew Hutzler, Reginald Frye, Timothy S. Tracy, Stephen C. Strom, Thomas Lehmann, Catharina Y. W. Ang, Yan Yan Cui and Raman Venkataramanan
      Drug Metabolism and Disposition May 2004, 32 (5) 512-518; DOI: https://doi.org/10.1124/dmd.32.5.512
  2. Christensen, Magnus

    1. You have access
      THE IMPACT OF CYP2C9 GENETICS AND ORAL CONTRACEPTIVES ON CYTOCHROME P450 2C9 PHENOTYPE
      Mia Sandberg, Inger Johansson, Magnus Christensen, Anders Rane and Erik Eliasson
      Drug Metabolism and Disposition May 2004, 32 (5) 484-489; DOI: https://doi.org/10.1124/dmd.32.5.484
  3. Conney, Allan H.

    1. You have access
      STRONG INHIBITORY EFFECTS OF COMMON TEA CATECHINS AND BIOFLAVONOIDS ON THE O-METHYLATION OF CATECHOL ESTROGENS CATALYZED BY HUMAN LIVER CYTOSOLIC CATECHOL-O-METHYLTRANSFERASE
      Mime Nagai, Allan H. Conney and Bao Ting Zhu
      Drug Metabolism and Disposition May 2004, 32 (5) 497-504; DOI: https://doi.org/10.1124/dmd.32.5.497
  4. Covey, Joseph M.

    1. You have access
      IN VITRO METABOLISM OF THE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR, WORTMANNIN, BY CARBONYL REDUCTASE
      Julianne L. Holleran, Julien Fourcade, Merrill J. Egorin, Julie L. Eiseman, Robert A. Parise, Steven M. Musser, Kevin D. White, Joseph M. Covey, Gerald L. Forrest and Su-Shu Pan
      Drug Metabolism and Disposition May 2004, 32 (5) 490-496; DOI: https://doi.org/10.1124/dmd.32.5.490
  5. Cui, Yan Yan

    1. You have access
      INDUCTION AND INHIBITION OF CYTOCHROMES P450 BY THE ST. JOHN'S WORT CONSTITUENT HYPERFORIN IN HUMAN HEPATOCYTE CULTURES
      Bernard J. Komoroski, Shimin Zhang, Hongbo Cai, J. Matthew Hutzler, Reginald Frye, Timothy S. Tracy, Stephen C. Strom, Thomas Lehmann, Catharina Y. W. Ang, Yan Yan Cui and Raman Venkataramanan
      Drug Metabolism and Disposition May 2004, 32 (5) 512-518; DOI: https://doi.org/10.1124/dmd.32.5.512

D

  1. Davis, Wilhelmina I.

    1. You have access
      HYDROLYSIS OF IRINOTECAN AND ITS OXIDATIVE METABOLITES, 7-ETHYL-10-[4-N-(5-AMINOPENTANOIC ACID)-1-PIPERIDINO] CARBONYLOXYCAMPTOTHECIN AND 7-ETHYL-10-[4-(1-PIPERIDINO)-1-AMINO]-CARBONYLOXYCAMPTOTHECIN, BY HUMAN CARBOXYLESTERASES CES1A1, CES2, AND A NEWLY EXPRESSED CARBOXYLESTERASE ISOENZYME, CES3
      Sonal P. Sanghani, Sara K. Quinney, Tyler B. Fredenburg, Wilhelmina I. Davis, Daryl J. Murry and William F. Bosron
      Drug Metabolism and Disposition May 2004, 32 (5) 505-511; DOI: https://doi.org/10.1124/dmd.32.5.505
  2. Dickson, Janet

    1. You have access
      PHARMACOKINETICS AND METABOLISM OF LUMIRACOXIB IN HEALTHY MALE SUBJECTS
      James B. Mangold, Helen Gu, Lolita C. Rodriguez, Johanne Bonner, Janet Dickson and Christiane Rordorf
      Drug Metabolism and Disposition May 2004, 32 (5) 566-571; DOI: https://doi.org/10.1124/dmd.32.5.566
  3. Duffel, Michael W.

    1. You have access
      INFLUENCE OF PHENYLALANINES 77 AND 138 ON THE STEREOSPECIFICITY OF ARYL SULFOTRANSFERASE IV
      Jonathan J. Sheng, Atmaja Saxena and Michael W. Duffel
      Drug Metabolism and Disposition May 2004, 32 (5) 559-565; DOI: https://doi.org/10.1124/dmd.32.5.559

E

  1. Egorin, Merrill J.

    1. You have access
      IN VITRO METABOLISM OF THE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR, WORTMANNIN, BY CARBONYL REDUCTASE
      Julianne L. Holleran, Julien Fourcade, Merrill J. Egorin, Julie L. Eiseman, Robert A. Parise, Steven M. Musser, Kevin D. White, Joseph M. Covey, Gerald L. Forrest and Su-Shu Pan
      Drug Metabolism and Disposition May 2004, 32 (5) 490-496; DOI: https://doi.org/10.1124/dmd.32.5.490
  2. Eiseman, Julie L.

    1. You have access
      IN VITRO METABOLISM OF THE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR, WORTMANNIN, BY CARBONYL REDUCTASE
      Julianne L. Holleran, Julien Fourcade, Merrill J. Egorin, Julie L. Eiseman, Robert A. Parise, Steven M. Musser, Kevin D. White, Joseph M. Covey, Gerald L. Forrest and Su-Shu Pan
      Drug Metabolism and Disposition May 2004, 32 (5) 490-496; DOI: https://doi.org/10.1124/dmd.32.5.490
  3. Eliasson, Erik

    1. You have access
      THE IMPACT OF CYP2C9 GENETICS AND ORAL CONTRACEPTIVES ON CYTOCHROME P450 2C9 PHENOTYPE
      Mia Sandberg, Inger Johansson, Magnus Christensen, Anders Rane and Erik Eliasson
      Drug Metabolism and Disposition May 2004, 32 (5) 484-489; DOI: https://doi.org/10.1124/dmd.32.5.484

F

  1. Forrest, Gerald L.

    1. You have access
      IN VITRO METABOLISM OF THE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR, WORTMANNIN, BY CARBONYL REDUCTASE
      Julianne L. Holleran, Julien Fourcade, Merrill J. Egorin, Julie L. Eiseman, Robert A. Parise, Steven M. Musser, Kevin D. White, Joseph M. Covey, Gerald L. Forrest and Su-Shu Pan
      Drug Metabolism and Disposition May 2004, 32 (5) 490-496; DOI: https://doi.org/10.1124/dmd.32.5.490
  2. Fourcade, Julien

    1. You have access
      IN VITRO METABOLISM OF THE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR, WORTMANNIN, BY CARBONYL REDUCTASE
      Julianne L. Holleran, Julien Fourcade, Merrill J. Egorin, Julie L. Eiseman, Robert A. Parise, Steven M. Musser, Kevin D. White, Joseph M. Covey, Gerald L. Forrest and Su-Shu Pan
      Drug Metabolism and Disposition May 2004, 32 (5) 490-496; DOI: https://doi.org/10.1124/dmd.32.5.490
  3. Fredenburg, Tyler B.

    1. You have access
      HYDROLYSIS OF IRINOTECAN AND ITS OXIDATIVE METABOLITES, 7-ETHYL-10-[4-N-(5-AMINOPENTANOIC ACID)-1-PIPERIDINO] CARBONYLOXYCAMPTOTHECIN AND 7-ETHYL-10-[4-(1-PIPERIDINO)-1-AMINO]-CARBONYLOXYCAMPTOTHECIN, BY HUMAN CARBOXYLESTERASES CES1A1, CES2, AND A NEWLY EXPRESSED CARBOXYLESTERASE ISOENZYME, CES3
      Sonal P. Sanghani, Sara K. Quinney, Tyler B. Fredenburg, Wilhelmina I. Davis, Daryl J. Murry and William F. Bosron
      Drug Metabolism and Disposition May 2004, 32 (5) 505-511; DOI: https://doi.org/10.1124/dmd.32.5.505
  4. Frye, Reginald

    1. You have access
      INDUCTION AND INHIBITION OF CYTOCHROMES P450 BY THE ST. JOHN'S WORT CONSTITUENT HYPERFORIN IN HUMAN HEPATOCYTE CULTURES
      Bernard J. Komoroski, Shimin Zhang, Hongbo Cai, J. Matthew Hutzler, Reginald Frye, Timothy S. Tracy, Stephen C. Strom, Thomas Lehmann, Catharina Y. W. Ang, Yan Yan Cui and Raman Venkataramanan
      Drug Metabolism and Disposition May 2004, 32 (5) 512-518; DOI: https://doi.org/10.1124/dmd.32.5.512

G

  1. Gibson, G. Gordon

    1. You have access
      ROLE OF Sp1, C/EBPα, HNF3, AND PXR IN THE BASAL- AND XENOBIOTIC-MEDIATED REGULATION OF THE CYP3A4 GENE
      Vincent Bombail, Kevin Taylor, G. Gordon Gibson and Nick Plant
      Drug Metabolism and Disposition May 2004, 32 (5) 525-535; DOI: https://doi.org/10.1124/dmd.32.5.525
  2. Griffin, Sarah J.

    1. You have access
      COMPARISON OF FRESH AND CRYOPRESERVED RAT HEPATOCYTE SUSPENSIONS FOR THE PREDICTION OF IN VITRO INTRINSIC CLEARANCE
      Sarah J. Griffin and J. Brian Houston
      Drug Metabolism and Disposition May 2004, 32 (5) 552-558; DOI: https://doi.org/10.1124/dmd.32.5.552
  3. Gu, Helen

    1. You have access
      PHARMACOKINETICS AND METABOLISM OF LUMIRACOXIB IN HEALTHY MALE SUBJECTS
      James B. Mangold, Helen Gu, Lolita C. Rodriguez, Johanne Bonner, Janet Dickson and Christiane Rordorf
      Drug Metabolism and Disposition May 2004, 32 (5) 566-571; DOI: https://doi.org/10.1124/dmd.32.5.566

H

  1. Hallifax, David

    1. You have access
      QUANTITATIVE PREDICTION OF THE IN VIVO INHIBITION OF DIAZEPAM METABOLISM BY OMEPRAZOLE USING RAT LIVER MICROSOMES AND HEPATOCYTES
      Hannah M. Jones, David Hallifax and J. Brian Houston
      Drug Metabolism and Disposition May 2004, 32 (5) 572-580; DOI: https://doi.org/10.1124/dmd.32.5.572
  2. Holleran, Julianne L.

    1. You have access
      IN VITRO METABOLISM OF THE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR, WORTMANNIN, BY CARBONYL REDUCTASE
      Julianne L. Holleran, Julien Fourcade, Merrill J. Egorin, Julie L. Eiseman, Robert A. Parise, Steven M. Musser, Kevin D. White, Joseph M. Covey, Gerald L. Forrest and Su-Shu Pan
      Drug Metabolism and Disposition May 2004, 32 (5) 490-496; DOI: https://doi.org/10.1124/dmd.32.5.490
  3. Houston, J. Brian

    1. You have access
      COMPARISON OF FRESH AND CRYOPRESERVED RAT HEPATOCYTE SUSPENSIONS FOR THE PREDICTION OF IN VITRO INTRINSIC CLEARANCE
      Sarah J. Griffin and J. Brian Houston
      Drug Metabolism and Disposition May 2004, 32 (5) 552-558; DOI: https://doi.org/10.1124/dmd.32.5.552
    2. You have access
      QUANTITATIVE PREDICTION OF THE IN VIVO INHIBITION OF DIAZEPAM METABOLISM BY OMEPRAZOLE USING RAT LIVER MICROSOMES AND HEPATOCYTES
      Hannah M. Jones, David Hallifax and J. Brian Houston
      Drug Metabolism and Disposition May 2004, 32 (5) 572-580; DOI: https://doi.org/10.1124/dmd.32.5.572
  4. Hutzler, J. Matthew

    1. You have access
      INDUCTION AND INHIBITION OF CYTOCHROMES P450 BY THE ST. JOHN'S WORT CONSTITUENT HYPERFORIN IN HUMAN HEPATOCYTE CULTURES
      Bernard J. Komoroski, Shimin Zhang, Hongbo Cai, J. Matthew Hutzler, Reginald Frye, Timothy S. Tracy, Stephen C. Strom, Thomas Lehmann, Catharina Y. W. Ang, Yan Yan Cui and Raman Venkataramanan
      Drug Metabolism and Disposition May 2004, 32 (5) 512-518; DOI: https://doi.org/10.1124/dmd.32.5.512

I

  1. Igarashi, Takashi

    1. You have access
      INFLUX AND EFFLUX TRANSPORT OF H1-ANTAGONIST EPINASTINE ACROSS THE BLOOD-BRAIN BARRIER
      Naoki Ishiguro, Takashi Nozawa, Akiko Tsujihata, Asami Saito, Wataru Kishimoto, Kazutoshi Yokoyama, Takafumi Yotsumoto, Kenji Sakai, Takashi Igarashi and Ikumi Tamai
      Drug Metabolism and Disposition May 2004, 32 (5) 519-524; DOI: https://doi.org/10.1124/dmd.32.5.519
  2. Ishiguro, Naoki

    1. You have access
      INFLUX AND EFFLUX TRANSPORT OF H1-ANTAGONIST EPINASTINE ACROSS THE BLOOD-BRAIN BARRIER
      Naoki Ishiguro, Takashi Nozawa, Akiko Tsujihata, Asami Saito, Wataru Kishimoto, Kazutoshi Yokoyama, Takafumi Yotsumoto, Kenji Sakai, Takashi Igarashi and Ikumi Tamai
      Drug Metabolism and Disposition May 2004, 32 (5) 519-524; DOI: https://doi.org/10.1124/dmd.32.5.519

J

  1. Johansson, Inger

    1. You have access
      THE IMPACT OF CYP2C9 GENETICS AND ORAL CONTRACEPTIVES ON CYTOCHROME P450 2C9 PHENOTYPE
      Mia Sandberg, Inger Johansson, Magnus Christensen, Anders Rane and Erik Eliasson
      Drug Metabolism and Disposition May 2004, 32 (5) 484-489; DOI: https://doi.org/10.1124/dmd.32.5.484
  2. Jones, Hannah M.

    1. You have access
      QUANTITATIVE PREDICTION OF THE IN VIVO INHIBITION OF DIAZEPAM METABOLISM BY OMEPRAZOLE USING RAT LIVER MICROSOMES AND HEPATOCYTES
      Hannah M. Jones, David Hallifax and J. Brian Houston
      Drug Metabolism and Disposition May 2004, 32 (5) 572-580; DOI: https://doi.org/10.1124/dmd.32.5.572

K

  1. Kishimoto, Wataru

    1. You have access
      INFLUX AND EFFLUX TRANSPORT OF H1-ANTAGONIST EPINASTINE ACROSS THE BLOOD-BRAIN BARRIER
      Naoki Ishiguro, Takashi Nozawa, Akiko Tsujihata, Asami Saito, Wataru Kishimoto, Kazutoshi Yokoyama, Takafumi Yotsumoto, Kenji Sakai, Takashi Igarashi and Ikumi Tamai
      Drug Metabolism and Disposition May 2004, 32 (5) 519-524; DOI: https://doi.org/10.1124/dmd.32.5.519
  2. Klunk, Lewis J.

    1. You have access
      AMIDE N-GLUCURONIDATION OF MAXIPOST CATALYZED BY UDP-GLUCURONOSYLTRANSFERASE 2B7 IN HUMANS
      Donglu Zhang, Weiping Zhao, Vikram A. Roongta, James G. Mitroka, Lewis J. Klunk and Mingshe Zhu
      Drug Metabolism and Disposition May 2004, 32 (5) 545-551; DOI: https://doi.org/10.1124/dmd.32.5.545
  3. Kobayashi, Yasuna

    1. You have access
      RENAL TRANSPORT OF ORGANIC COMPOUNDS MEDIATED BY MOUSE ORGANIC ANION TRANSPORTER 3 (MOAT3): FURTHER SUBSTRATE SPECIFICITY OF MOAT3
      Yasuna Kobayashi, Naomi Ohshiro, Ayumi Tsuchiya, Noriko Kohyama, Masayuki Ohbayashi and Toshinori Yamamoto
      Drug Metabolism and Disposition May 2004, 32 (5) 479-483; DOI: https://doi.org/10.1124/dmd.32.5.479
  4. Kohyama, Noriko

    1. You have access
      RENAL TRANSPORT OF ORGANIC COMPOUNDS MEDIATED BY MOUSE ORGANIC ANION TRANSPORTER 3 (MOAT3): FURTHER SUBSTRATE SPECIFICITY OF MOAT3
      Yasuna Kobayashi, Naomi Ohshiro, Ayumi Tsuchiya, Noriko Kohyama, Masayuki Ohbayashi and Toshinori Yamamoto
      Drug Metabolism and Disposition May 2004, 32 (5) 479-483; DOI: https://doi.org/10.1124/dmd.32.5.479
  5. Komoroski, Bernard J.

    1. You have access
      INDUCTION AND INHIBITION OF CYTOCHROMES P450 BY THE ST. JOHN'S WORT CONSTITUENT HYPERFORIN IN HUMAN HEPATOCYTE CULTURES
      Bernard J. Komoroski, Shimin Zhang, Hongbo Cai, J. Matthew Hutzler, Reginald Frye, Timothy S. Tracy, Stephen C. Strom, Thomas Lehmann, Catharina Y. W. Ang, Yan Yan Cui and Raman Venkataramanan
      Drug Metabolism and Disposition May 2004, 32 (5) 512-518; DOI: https://doi.org/10.1124/dmd.32.5.512

L

  1. Lanusse, C.

    1. You have access
      COMPARATIVE HEPATIC AND EXTRAHEPATIC ENANTIOSELECTIVE SULFOXIDATION OF ALBENDAZOLE AND FENBENDAZOLE IN SHEEP AND CATTLE
      G. Virkel, A. Lifschitz, J. Sallovitz, A. Pis and C. Lanusse
      Drug Metabolism and Disposition May 2004, 32 (5) 536-544; DOI: https://doi.org/10.1124/dmd.32.5.536
  2. Lehmann, Thomas

    1. You have access
      INDUCTION AND INHIBITION OF CYTOCHROMES P450 BY THE ST. JOHN'S WORT CONSTITUENT HYPERFORIN IN HUMAN HEPATOCYTE CULTURES
      Bernard J. Komoroski, Shimin Zhang, Hongbo Cai, J. Matthew Hutzler, Reginald Frye, Timothy S. Tracy, Stephen C. Strom, Thomas Lehmann, Catharina Y. W. Ang, Yan Yan Cui and Raman Venkataramanan
      Drug Metabolism and Disposition May 2004, 32 (5) 512-518; DOI: https://doi.org/10.1124/dmd.32.5.512
  3. Lifschitz, A.

    1. You have access
      COMPARATIVE HEPATIC AND EXTRAHEPATIC ENANTIOSELECTIVE SULFOXIDATION OF ALBENDAZOLE AND FENBENDAZOLE IN SHEEP AND CATTLE
      G. Virkel, A. Lifschitz, J. Sallovitz, A. Pis and C. Lanusse
      Drug Metabolism and Disposition May 2004, 32 (5) 536-544; DOI: https://doi.org/10.1124/dmd.32.5.536

M

  1. Ma, Bennett

    1. You have access
      CYTOCHROME P450 2C8 (CYP2C8)-MEDIATED HYDROXYLATION OF AN ENDOTHELIN ETA RECEPTOR ANTAGONIST IN HUMAN LIVER MICROSOMES
      Bennett Ma, Raju Subramanian, Michael L. Schrag, A. David Rodrigues and Cuyue Tang
      Drug Metabolism and Disposition May 2004, 32 (5) 473-478; DOI: https://doi.org/10.1124/dmd.32.5.473
  2. Mangold, James B.

    1. You have access
      PHARMACOKINETICS AND METABOLISM OF LUMIRACOXIB IN HEALTHY MALE SUBJECTS
      James B. Mangold, Helen Gu, Lolita C. Rodriguez, Johanne Bonner, Janet Dickson and Christiane Rordorf
      Drug Metabolism and Disposition May 2004, 32 (5) 566-571; DOI: https://doi.org/10.1124/dmd.32.5.566
  3. Mitroka, James G.

    1. You have access
      AMIDE N-GLUCURONIDATION OF MAXIPOST CATALYZED BY UDP-GLUCURONOSYLTRANSFERASE 2B7 IN HUMANS
      Donglu Zhang, Weiping Zhao, Vikram A. Roongta, James G. Mitroka, Lewis J. Klunk and Mingshe Zhu
      Drug Metabolism and Disposition May 2004, 32 (5) 545-551; DOI: https://doi.org/10.1124/dmd.32.5.545
  4. Murry, Daryl J.

    1. You have access
      HYDROLYSIS OF IRINOTECAN AND ITS OXIDATIVE METABOLITES, 7-ETHYL-10-[4-N-(5-AMINOPENTANOIC ACID)-1-PIPERIDINO] CARBONYLOXYCAMPTOTHECIN AND 7-ETHYL-10-[4-(1-PIPERIDINO)-1-AMINO]-CARBONYLOXYCAMPTOTHECIN, BY HUMAN CARBOXYLESTERASES CES1A1, CES2, AND A NEWLY EXPRESSED CARBOXYLESTERASE ISOENZYME, CES3
      Sonal P. Sanghani, Sara K. Quinney, Tyler B. Fredenburg, Wilhelmina I. Davis, Daryl J. Murry and William F. Bosron
      Drug Metabolism and Disposition May 2004, 32 (5) 505-511; DOI: https://doi.org/10.1124/dmd.32.5.505
  5. Musser, Steven M.

    1. You have access
      IN VITRO METABOLISM OF THE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR, WORTMANNIN, BY CARBONYL REDUCTASE
      Julianne L. Holleran, Julien Fourcade, Merrill J. Egorin, Julie L. Eiseman, Robert A. Parise, Steven M. Musser, Kevin D. White, Joseph M. Covey, Gerald L. Forrest and Su-Shu Pan
      Drug Metabolism and Disposition May 2004, 32 (5) 490-496; DOI: https://doi.org/10.1124/dmd.32.5.490

N

  1. Nagai, Mime

    1. You have access
      STRONG INHIBITORY EFFECTS OF COMMON TEA CATECHINS AND BIOFLAVONOIDS ON THE O-METHYLATION OF CATECHOL ESTROGENS CATALYZED BY HUMAN LIVER CYTOSOLIC CATECHOL-O-METHYLTRANSFERASE
      Mime Nagai, Allan H. Conney and Bao Ting Zhu
      Drug Metabolism and Disposition May 2004, 32 (5) 497-504; DOI: https://doi.org/10.1124/dmd.32.5.497
  2. Nozawa, Takashi

    1. You have access
      INFLUX AND EFFLUX TRANSPORT OF H1-ANTAGONIST EPINASTINE ACROSS THE BLOOD-BRAIN BARRIER
      Naoki Ishiguro, Takashi Nozawa, Akiko Tsujihata, Asami Saito, Wataru Kishimoto, Kazutoshi Yokoyama, Takafumi Yotsumoto, Kenji Sakai, Takashi Igarashi and Ikumi Tamai
      Drug Metabolism and Disposition May 2004, 32 (5) 519-524; DOI: https://doi.org/10.1124/dmd.32.5.519

O

  1. Ohbayashi, Masayuki

    1. You have access
      RENAL TRANSPORT OF ORGANIC COMPOUNDS MEDIATED BY MOUSE ORGANIC ANION TRANSPORTER 3 (MOAT3): FURTHER SUBSTRATE SPECIFICITY OF MOAT3
      Yasuna Kobayashi, Naomi Ohshiro, Ayumi Tsuchiya, Noriko Kohyama, Masayuki Ohbayashi and Toshinori Yamamoto
      Drug Metabolism and Disposition May 2004, 32 (5) 479-483; DOI: https://doi.org/10.1124/dmd.32.5.479
  2. Ohshiro, Naomi

    1. You have access
      RENAL TRANSPORT OF ORGANIC COMPOUNDS MEDIATED BY MOUSE ORGANIC ANION TRANSPORTER 3 (MOAT3): FURTHER SUBSTRATE SPECIFICITY OF MOAT3
      Yasuna Kobayashi, Naomi Ohshiro, Ayumi Tsuchiya, Noriko Kohyama, Masayuki Ohbayashi and Toshinori Yamamoto
      Drug Metabolism and Disposition May 2004, 32 (5) 479-483; DOI: https://doi.org/10.1124/dmd.32.5.479

P

  1. Pan, Su-Shu

    1. You have access
      IN VITRO METABOLISM OF THE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR, WORTMANNIN, BY CARBONYL REDUCTASE
      Julianne L. Holleran, Julien Fourcade, Merrill J. Egorin, Julie L. Eiseman, Robert A. Parise, Steven M. Musser, Kevin D. White, Joseph M. Covey, Gerald L. Forrest and Su-Shu Pan
      Drug Metabolism and Disposition May 2004, 32 (5) 490-496; DOI: https://doi.org/10.1124/dmd.32.5.490
  2. Parise, Robert A.

    1. You have access
      IN VITRO METABOLISM OF THE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR, WORTMANNIN, BY CARBONYL REDUCTASE
      Julianne L. Holleran, Julien Fourcade, Merrill J. Egorin, Julie L. Eiseman, Robert A. Parise, Steven M. Musser, Kevin D. White, Joseph M. Covey, Gerald L. Forrest and Su-Shu Pan
      Drug Metabolism and Disposition May 2004, 32 (5) 490-496; DOI: https://doi.org/10.1124/dmd.32.5.490
  3. Pis, A.

    1. You have access
      COMPARATIVE HEPATIC AND EXTRAHEPATIC ENANTIOSELECTIVE SULFOXIDATION OF ALBENDAZOLE AND FENBENDAZOLE IN SHEEP AND CATTLE
      G. Virkel, A. Lifschitz, J. Sallovitz, A. Pis and C. Lanusse
      Drug Metabolism and Disposition May 2004, 32 (5) 536-544; DOI: https://doi.org/10.1124/dmd.32.5.536
  4. Plant, Nick

    1. You have access
      ROLE OF Sp1, C/EBPα, HNF3, AND PXR IN THE BASAL- AND XENOBIOTIC-MEDIATED REGULATION OF THE CYP3A4 GENE
      Vincent Bombail, Kevin Taylor, G. Gordon Gibson and Nick Plant
      Drug Metabolism and Disposition May 2004, 32 (5) 525-535; DOI: https://doi.org/10.1124/dmd.32.5.525

Q

  1. Quinney, Sara K.

    1. You have access
      HYDROLYSIS OF IRINOTECAN AND ITS OXIDATIVE METABOLITES, 7-ETHYL-10-[4-N-(5-AMINOPENTANOIC ACID)-1-PIPERIDINO] CARBONYLOXYCAMPTOTHECIN AND 7-ETHYL-10-[4-(1-PIPERIDINO)-1-AMINO]-CARBONYLOXYCAMPTOTHECIN, BY HUMAN CARBOXYLESTERASES CES1A1, CES2, AND A NEWLY EXPRESSED CARBOXYLESTERASE ISOENZYME, CES3
      Sonal P. Sanghani, Sara K. Quinney, Tyler B. Fredenburg, Wilhelmina I. Davis, Daryl J. Murry and William F. Bosron
      Drug Metabolism and Disposition May 2004, 32 (5) 505-511; DOI: https://doi.org/10.1124/dmd.32.5.505

R

  1. Rane, Anders

    1. You have access
      THE IMPACT OF CYP2C9 GENETICS AND ORAL CONTRACEPTIVES ON CYTOCHROME P450 2C9 PHENOTYPE
      Mia Sandberg, Inger Johansson, Magnus Christensen, Anders Rane and Erik Eliasson
      Drug Metabolism and Disposition May 2004, 32 (5) 484-489; DOI: https://doi.org/10.1124/dmd.32.5.484
  2. Rodrigues, A. David

    1. You have access
      CYTOCHROME P450 2C8 (CYP2C8)-MEDIATED HYDROXYLATION OF AN ENDOTHELIN ETA RECEPTOR ANTAGONIST IN HUMAN LIVER MICROSOMES
      Bennett Ma, Raju Subramanian, Michael L. Schrag, A. David Rodrigues and Cuyue Tang
      Drug Metabolism and Disposition May 2004, 32 (5) 473-478; DOI: https://doi.org/10.1124/dmd.32.5.473
  3. Rodriguez, Lolita C.

    1. You have access
      PHARMACOKINETICS AND METABOLISM OF LUMIRACOXIB IN HEALTHY MALE SUBJECTS
      James B. Mangold, Helen Gu, Lolita C. Rodriguez, Johanne Bonner, Janet Dickson and Christiane Rordorf
      Drug Metabolism and Disposition May 2004, 32 (5) 566-571; DOI: https://doi.org/10.1124/dmd.32.5.566
  4. Roongta, Vikram A.

    1. You have access
      AMIDE N-GLUCURONIDATION OF MAXIPOST CATALYZED BY UDP-GLUCURONOSYLTRANSFERASE 2B7 IN HUMANS
      Donglu Zhang, Weiping Zhao, Vikram A. Roongta, James G. Mitroka, Lewis J. Klunk and Mingshe Zhu
      Drug Metabolism and Disposition May 2004, 32 (5) 545-551; DOI: https://doi.org/10.1124/dmd.32.5.545
  5. Rordorf, Christiane

    1. You have access
      PHARMACOKINETICS AND METABOLISM OF LUMIRACOXIB IN HEALTHY MALE SUBJECTS
      James B. Mangold, Helen Gu, Lolita C. Rodriguez, Johanne Bonner, Janet Dickson and Christiane Rordorf
      Drug Metabolism and Disposition May 2004, 32 (5) 566-571; DOI: https://doi.org/10.1124/dmd.32.5.566

S

  1. Saito, Asami

    1. You have access
      INFLUX AND EFFLUX TRANSPORT OF H1-ANTAGONIST EPINASTINE ACROSS THE BLOOD-BRAIN BARRIER
      Naoki Ishiguro, Takashi Nozawa, Akiko Tsujihata, Asami Saito, Wataru Kishimoto, Kazutoshi Yokoyama, Takafumi Yotsumoto, Kenji Sakai, Takashi Igarashi and Ikumi Tamai
      Drug Metabolism and Disposition May 2004, 32 (5) 519-524; DOI: https://doi.org/10.1124/dmd.32.5.519
  2. Sakai, Kenji

    1. You have access
      INFLUX AND EFFLUX TRANSPORT OF H1-ANTAGONIST EPINASTINE ACROSS THE BLOOD-BRAIN BARRIER
      Naoki Ishiguro, Takashi Nozawa, Akiko Tsujihata, Asami Saito, Wataru Kishimoto, Kazutoshi Yokoyama, Takafumi Yotsumoto, Kenji Sakai, Takashi Igarashi and Ikumi Tamai
      Drug Metabolism and Disposition May 2004, 32 (5) 519-524; DOI: https://doi.org/10.1124/dmd.32.5.519
  3. Sallovitz, J.

    1. You have access
      COMPARATIVE HEPATIC AND EXTRAHEPATIC ENANTIOSELECTIVE SULFOXIDATION OF ALBENDAZOLE AND FENBENDAZOLE IN SHEEP AND CATTLE
      G. Virkel, A. Lifschitz, J. Sallovitz, A. Pis and C. Lanusse
      Drug Metabolism and Disposition May 2004, 32 (5) 536-544; DOI: https://doi.org/10.1124/dmd.32.5.536
  4. Sandberg, Mia

    1. You have access
      THE IMPACT OF CYP2C9 GENETICS AND ORAL CONTRACEPTIVES ON CYTOCHROME P450 2C9 PHENOTYPE
      Mia Sandberg, Inger Johansson, Magnus Christensen, Anders Rane and Erik Eliasson
      Drug Metabolism and Disposition May 2004, 32 (5) 484-489; DOI: https://doi.org/10.1124/dmd.32.5.484
  5. Sanghani, Sonal P.

    1. You have access
      HYDROLYSIS OF IRINOTECAN AND ITS OXIDATIVE METABOLITES, 7-ETHYL-10-[4-N-(5-AMINOPENTANOIC ACID)-1-PIPERIDINO] CARBONYLOXYCAMPTOTHECIN AND 7-ETHYL-10-[4-(1-PIPERIDINO)-1-AMINO]-CARBONYLOXYCAMPTOTHECIN, BY HUMAN CARBOXYLESTERASES CES1A1, CES2, AND A NEWLY EXPRESSED CARBOXYLESTERASE ISOENZYME, CES3
      Sonal P. Sanghani, Sara K. Quinney, Tyler B. Fredenburg, Wilhelmina I. Davis, Daryl J. Murry and William F. Bosron
      Drug Metabolism and Disposition May 2004, 32 (5) 505-511; DOI: https://doi.org/10.1124/dmd.32.5.505
  6. Saxena, Atmaja

    1. You have access
      INFLUENCE OF PHENYLALANINES 77 AND 138 ON THE STEREOSPECIFICITY OF ARYL SULFOTRANSFERASE IV
      Jonathan J. Sheng, Atmaja Saxena and Michael W. Duffel
      Drug Metabolism and Disposition May 2004, 32 (5) 559-565; DOI: https://doi.org/10.1124/dmd.32.5.559
  7. Schrag, Michael L.

    1. You have access
      CYTOCHROME P450 2C8 (CYP2C8)-MEDIATED HYDROXYLATION OF AN ENDOTHELIN ETA RECEPTOR ANTAGONIST IN HUMAN LIVER MICROSOMES
      Bennett Ma, Raju Subramanian, Michael L. Schrag, A. David Rodrigues and Cuyue Tang
      Drug Metabolism and Disposition May 2004, 32 (5) 473-478; DOI: https://doi.org/10.1124/dmd.32.5.473
  8. Sheng, Jonathan J.

    1. You have access
      INFLUENCE OF PHENYLALANINES 77 AND 138 ON THE STEREOSPECIFICITY OF ARYL SULFOTRANSFERASE IV
      Jonathan J. Sheng, Atmaja Saxena and Michael W. Duffel
      Drug Metabolism and Disposition May 2004, 32 (5) 559-565; DOI: https://doi.org/10.1124/dmd.32.5.559
  9. Strom, Stephen C.

    1. You have access
      INDUCTION AND INHIBITION OF CYTOCHROMES P450 BY THE ST. JOHN'S WORT CONSTITUENT HYPERFORIN IN HUMAN HEPATOCYTE CULTURES
      Bernard J. Komoroski, Shimin Zhang, Hongbo Cai, J. Matthew Hutzler, Reginald Frye, Timothy S. Tracy, Stephen C. Strom, Thomas Lehmann, Catharina Y. W. Ang, Yan Yan Cui and Raman Venkataramanan
      Drug Metabolism and Disposition May 2004, 32 (5) 512-518; DOI: https://doi.org/10.1124/dmd.32.5.512
  10. Subramanian, Raju

    1. You have access
      CYTOCHROME P450 2C8 (CYP2C8)-MEDIATED HYDROXYLATION OF AN ENDOTHELIN ETA RECEPTOR ANTAGONIST IN HUMAN LIVER MICROSOMES
      Bennett Ma, Raju Subramanian, Michael L. Schrag, A. David Rodrigues and Cuyue Tang
      Drug Metabolism and Disposition May 2004, 32 (5) 473-478; DOI: https://doi.org/10.1124/dmd.32.5.473

T

  1. Tamai, Ikumi

    1. You have access
      INFLUX AND EFFLUX TRANSPORT OF H1-ANTAGONIST EPINASTINE ACROSS THE BLOOD-BRAIN BARRIER
      Naoki Ishiguro, Takashi Nozawa, Akiko Tsujihata, Asami Saito, Wataru Kishimoto, Kazutoshi Yokoyama, Takafumi Yotsumoto, Kenji Sakai, Takashi Igarashi and Ikumi Tamai
      Drug Metabolism and Disposition May 2004, 32 (5) 519-524; DOI: https://doi.org/10.1124/dmd.32.5.519
  2. Tang, Cuyue

    1. You have access
      CYTOCHROME P450 2C8 (CYP2C8)-MEDIATED HYDROXYLATION OF AN ENDOTHELIN ETA RECEPTOR ANTAGONIST IN HUMAN LIVER MICROSOMES
      Bennett Ma, Raju Subramanian, Michael L. Schrag, A. David Rodrigues and Cuyue Tang
      Drug Metabolism and Disposition May 2004, 32 (5) 473-478; DOI: https://doi.org/10.1124/dmd.32.5.473
  3. Taylor, Kevin

    1. You have access
      ROLE OF Sp1, C/EBPα, HNF3, AND PXR IN THE BASAL- AND XENOBIOTIC-MEDIATED REGULATION OF THE CYP3A4 GENE
      Vincent Bombail, Kevin Taylor, G. Gordon Gibson and Nick Plant
      Drug Metabolism and Disposition May 2004, 32 (5) 525-535; DOI: https://doi.org/10.1124/dmd.32.5.525
  4. Tracy, Timothy S.

    1. You have access
      INDUCTION AND INHIBITION OF CYTOCHROMES P450 BY THE ST. JOHN'S WORT CONSTITUENT HYPERFORIN IN HUMAN HEPATOCYTE CULTURES
      Bernard J. Komoroski, Shimin Zhang, Hongbo Cai, J. Matthew Hutzler, Reginald Frye, Timothy S. Tracy, Stephen C. Strom, Thomas Lehmann, Catharina Y. W. Ang, Yan Yan Cui and Raman Venkataramanan
      Drug Metabolism and Disposition May 2004, 32 (5) 512-518; DOI: https://doi.org/10.1124/dmd.32.5.512
  5. Tsuchiya, Ayumi

    1. You have access
      RENAL TRANSPORT OF ORGANIC COMPOUNDS MEDIATED BY MOUSE ORGANIC ANION TRANSPORTER 3 (MOAT3): FURTHER SUBSTRATE SPECIFICITY OF MOAT3
      Yasuna Kobayashi, Naomi Ohshiro, Ayumi Tsuchiya, Noriko Kohyama, Masayuki Ohbayashi and Toshinori Yamamoto
      Drug Metabolism and Disposition May 2004, 32 (5) 479-483; DOI: https://doi.org/10.1124/dmd.32.5.479
  6. Tsujihata, Akiko

    1. You have access
      INFLUX AND EFFLUX TRANSPORT OF H1-ANTAGONIST EPINASTINE ACROSS THE BLOOD-BRAIN BARRIER
      Naoki Ishiguro, Takashi Nozawa, Akiko Tsujihata, Asami Saito, Wataru Kishimoto, Kazutoshi Yokoyama, Takafumi Yotsumoto, Kenji Sakai, Takashi Igarashi and Ikumi Tamai
      Drug Metabolism and Disposition May 2004, 32 (5) 519-524; DOI: https://doi.org/10.1124/dmd.32.5.519

V

  1. Venkataramanan, Raman

    1. You have access
      INDUCTION AND INHIBITION OF CYTOCHROMES P450 BY THE ST. JOHN'S WORT CONSTITUENT HYPERFORIN IN HUMAN HEPATOCYTE CULTURES
      Bernard J. Komoroski, Shimin Zhang, Hongbo Cai, J. Matthew Hutzler, Reginald Frye, Timothy S. Tracy, Stephen C. Strom, Thomas Lehmann, Catharina Y. W. Ang, Yan Yan Cui and Raman Venkataramanan
      Drug Metabolism and Disposition May 2004, 32 (5) 512-518; DOI: https://doi.org/10.1124/dmd.32.5.512
  2. Virkel, G.

    1. You have access
      COMPARATIVE HEPATIC AND EXTRAHEPATIC ENANTIOSELECTIVE SULFOXIDATION OF ALBENDAZOLE AND FENBENDAZOLE IN SHEEP AND CATTLE
      G. Virkel, A. Lifschitz, J. Sallovitz, A. Pis and C. Lanusse
      Drug Metabolism and Disposition May 2004, 32 (5) 536-544; DOI: https://doi.org/10.1124/dmd.32.5.536

W

  1. White, Kevin D.

    1. You have access
      IN VITRO METABOLISM OF THE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR, WORTMANNIN, BY CARBONYL REDUCTASE
      Julianne L. Holleran, Julien Fourcade, Merrill J. Egorin, Julie L. Eiseman, Robert A. Parise, Steven M. Musser, Kevin D. White, Joseph M. Covey, Gerald L. Forrest and Su-Shu Pan
      Drug Metabolism and Disposition May 2004, 32 (5) 490-496; DOI: https://doi.org/10.1124/dmd.32.5.490

Y

  1. Yamamoto, Toshinori

    1. You have access
      RENAL TRANSPORT OF ORGANIC COMPOUNDS MEDIATED BY MOUSE ORGANIC ANION TRANSPORTER 3 (MOAT3): FURTHER SUBSTRATE SPECIFICITY OF MOAT3
      Yasuna Kobayashi, Naomi Ohshiro, Ayumi Tsuchiya, Noriko Kohyama, Masayuki Ohbayashi and Toshinori Yamamoto
      Drug Metabolism and Disposition May 2004, 32 (5) 479-483; DOI: https://doi.org/10.1124/dmd.32.5.479
  2. Yokoyama, Kazutoshi

    1. You have access
      INFLUX AND EFFLUX TRANSPORT OF H1-ANTAGONIST EPINASTINE ACROSS THE BLOOD-BRAIN BARRIER
      Naoki Ishiguro, Takashi Nozawa, Akiko Tsujihata, Asami Saito, Wataru Kishimoto, Kazutoshi Yokoyama, Takafumi Yotsumoto, Kenji Sakai, Takashi Igarashi and Ikumi Tamai
      Drug Metabolism and Disposition May 2004, 32 (5) 519-524; DOI: https://doi.org/10.1124/dmd.32.5.519
  3. Yotsumoto, Takafumi

    1. You have access
      INFLUX AND EFFLUX TRANSPORT OF H1-ANTAGONIST EPINASTINE ACROSS THE BLOOD-BRAIN BARRIER
      Naoki Ishiguro, Takashi Nozawa, Akiko Tsujihata, Asami Saito, Wataru Kishimoto, Kazutoshi Yokoyama, Takafumi Yotsumoto, Kenji Sakai, Takashi Igarashi and Ikumi Tamai
      Drug Metabolism and Disposition May 2004, 32 (5) 519-524; DOI: https://doi.org/10.1124/dmd.32.5.519

Z

  1. Zhang, Donglu

    1. You have access
      AMIDE N-GLUCURONIDATION OF MAXIPOST CATALYZED BY UDP-GLUCURONOSYLTRANSFERASE 2B7 IN HUMANS
      Donglu Zhang, Weiping Zhao, Vikram A. Roongta, James G. Mitroka, Lewis J. Klunk and Mingshe Zhu
      Drug Metabolism and Disposition May 2004, 32 (5) 545-551; DOI: https://doi.org/10.1124/dmd.32.5.545
  2. Zhang, Shimin

    1. You have access
      INDUCTION AND INHIBITION OF CYTOCHROMES P450 BY THE ST. JOHN'S WORT CONSTITUENT HYPERFORIN IN HUMAN HEPATOCYTE CULTURES
      Bernard J. Komoroski, Shimin Zhang, Hongbo Cai, J. Matthew Hutzler, Reginald Frye, Timothy S. Tracy, Stephen C. Strom, Thomas Lehmann, Catharina Y. W. Ang, Yan Yan Cui and Raman Venkataramanan
      Drug Metabolism and Disposition May 2004, 32 (5) 512-518; DOI: https://doi.org/10.1124/dmd.32.5.512
  3. Zhao, Weiping

    1. You have access
      AMIDE N-GLUCURONIDATION OF MAXIPOST CATALYZED BY UDP-GLUCURONOSYLTRANSFERASE 2B7 IN HUMANS
      Donglu Zhang, Weiping Zhao, Vikram A. Roongta, James G. Mitroka, Lewis J. Klunk and Mingshe Zhu
      Drug Metabolism and Disposition May 2004, 32 (5) 545-551; DOI: https://doi.org/10.1124/dmd.32.5.545
  4. Zhu, Bao Ting

    1. You have access
      STRONG INHIBITORY EFFECTS OF COMMON TEA CATECHINS AND BIOFLAVONOIDS ON THE O-METHYLATION OF CATECHOL ESTROGENS CATALYZED BY HUMAN LIVER CYTOSOLIC CATECHOL-O-METHYLTRANSFERASE
      Mime Nagai, Allan H. Conney and Bao Ting Zhu
      Drug Metabolism and Disposition May 2004, 32 (5) 497-504; DOI: https://doi.org/10.1124/dmd.32.5.497
  5. Zhu, Mingshe

    1. You have access
      AMIDE N-GLUCURONIDATION OF MAXIPOST CATALYZED BY UDP-GLUCURONOSYLTRANSFERASE 2B7 IN HUMANS
      Donglu Zhang, Weiping Zhao, Vikram A. Roongta, James G. Mitroka, Lewis J. Klunk and Mingshe Zhu
      Drug Metabolism and Disposition May 2004, 32 (5) 545-551; DOI: https://doi.org/10.1124/dmd.32.5.545
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 32 (5)
Drug Metabolism and Disposition
Vol. 32, Issue 5
1 May 2004
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics